Connect with us

Legal & Regulation

Direct Selling Association CBD Memo: Ingestible CBD-Infused Products Violate DSA Code of Ethics



Direct Selling Association CBD Memo: Ingestible CBD-Infused Products Violate DSA Code of Ethics

The Direct Selling Association (DSA) issued a memo last month concerning CBD. The memo stated, “ . . . it is the determination by this office that the sale of ingestible CBD (cannabidiol-based oils) products such as foodstuff, nutritional supplement, tincture or for any digestible means for humans or animals is violative of the DSA Code of Ethics.”

According to the memo, the association is instilling a 90-day window for member companies that sell CBD to not face citation under the association’s code of ethics. The 90-day window is based on the association’s desire to account for time for the FDA to “articulate a path forward” concerning the legality of the products.

Spencer Reese, a partner at Reese, Poyfair & Richards shared in a news article on Direct Selling News,

“I would be somewhat surprised to see the FDA have some new or concerted approach by the end of October. This is not a new issue. The Epidiolex pre-IND (investigational new drug) was filed back in 2014, so everybody knows CBD oil was the subject of extensive investigations and research as a drug as far back as then. It’s no secret that the FDA’s position on CBD is, because of the pre-approval of Epidiolex, that CBD oil is a drug; however, the FDA has done nothing about regulating it.”

The article also indicates that the DSA is providing additional communication to members. In terms of the sale of ingestible products containing BD, the association issued background materials and regulatory issues.

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email

Copyright © 2020 | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.